Moderna
MRNA
#1188
Rank
ยฃ14.35 B
Marketcap
ยฃ36.19
Share price
-3.35%
Change (1 day)
75.14%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -ยฃ2.07 Billion

According to Moderna 's latest financial reports the company's current earnings are ยฃ1.92 Billion. , an increase over its 2024 earnings that were of -ยฃ2.65 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -ยฃ2.04 Billion-23.03%
2024 -ยฃ2.65 Billion-8.22%
2023 -ยฃ2.89 Billion-140.65%
2022 ยฃ7.08 B-27.81%
2021 ยฃ9.81 B-1911.15%
2020 -ยฃ0.55 Billion44.7%
2019 -ยฃ0.38 Billion28.63%
2018 -ยฃ0.3 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ24.76 B-1,316.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ12.06 B-692.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
ยฃ16.54 B-913.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-ยฃ35.01 Million-98.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ86.84 Million-95.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ30.83 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.42 B-120.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
ยฃ0.25 B-112.51%๐Ÿ‡บ๐Ÿ‡ธ USA